 patients in the
Clopidogrel versus Aspirin in Patients at Risk of Ischaemic
Events143 trial. However, it costs more than aspirin, and
the subsequent Clopidogrel for High Atherothrombotic
Risk and Ischemic Stabilization, Management, and Avoidance144 trial showed that clopidogrel plus aspirin was
equivalent to aspirin alone in preventing vascular events in
patients with a prior stroke,